LEP and breast cancer: Further supporting the notion that leptin may reduce CD8+ T cell anti-tumor function in the context of obesity, a recent study found that leptin contributes to CD8+ tumor-infiltrating lymphocyte (TIL) dysfunction in a spontaneous breast cancer model (Zhang et al., 2020).